GE HealthCare Technologies Inc.
GEHC · Nasdaq
- $63.93
- $29.02B
- Open
- —
- —
- $63.89 - $65.27
- $58.75 - $89.77
- —
- —
- 2.73M
About GE HealthCare Technologies Inc.
GE HealthCare sells healthcare equipment and diagnostic solutions, with hospitals identified as important customers. Its offering includes the “heavy iron” infrastructure and vital diagnostics referenced in the supplied coverage, and it makes money through sales of those products and related healthcare solutions. The evidence does not provide a segment breakdown or the contribution of each business, so the revenue mix cannot be stated reliably. The company generated $20.6 billion of revenue and $2.1 billion of net income in fiscal 2025, up from $19.7 billion and $2.0 billion, respectively, in fiscal 2024.
Notable Price Movement
- Aug 3-7$71.775.51%
GE HealthCare rose $6.15, or 9.59%, from $64.11 to $70.26 over the supplied week. The move was dominated by a 12.1% surge to $71.90 on July 29, on volume of 15.3 million shares, after which the stock gave back most of that gain over the next two sessions, closing at $68.02 on July 31. It then recovered to consecutive closes of $69.73 and $70.26. The clearest company-specific support was coverage highlighting renewed hospital purchases of diagnostic and other capital equipment, alongside the availability of the company’s second-quarter 2026 earnings-call transcript. Broader markets were volatile amid chipmaker selloffs, oil moves, and a hawkish Federal Reserve backdrop.
